Prenatal Care

Essential Scope of Prenatal Care for FNP Practice

Prenatal care encompasses the systematic medical and nursing supervision of a woman during pregnancy. Its primary goals are to monitor maternal-fetal well-being, identify and manage risk factors, provide health education, and optimize outcomes for both mother and neonate. For the Family Nurse Practitioner (FNP), mastery of prenatal care is essential for board certification (e.g., AANP or ANCC FNP exams) and for safe, evidence-based clinical practice. ^[1]

High-yield exam content focuses on accurate dating of pregnancy, appropriate screening tests, identification of high-risk conditions, and the schedule of routine visits. Understanding the physiologic adaptations of pregnancy and their clinical implications is equally critical. ^[2]

Obstetric History Terms and Pregnancy Milestones

• Gravida: Total number of pregnancies a woman has had, regardless of outcome.
• Para: Number of pregnancies that have reached viability (typically ≥20 weeks gestation).
• TPAL: Acronym used to document obstetric history — Term births, Preterm births, Abortions (spontaneous or induced), and Living children.
• Estimated Due Date (EDD): Calculated using Naegele's rule (first day of last menstrual period + 280 days [40 weeks]) or confirmed by first-trimester ultrasound. ^[3]
• Fundal Height: Measurement from the pubic symphysis to the uterine fundus, typically correlating with gestational age in centimeters after 20 weeks.
• Quickening: First fetal movements felt by the mother, usually between 16–20 weeks.
• Lightening: Descent of the fetal presenting part into the pelvis before labor.

Routine Visit Schedule and Physiologic Adaptations

Schedule of Routine Prenatal Visits

The standard visit schedule recommended by ACOG is designed to provide timely screening and intervention. ^[4]

1. First visit (8–12 weeks): Comprehensive history, physical exam, dating ultrasound, baseline labs, and risk assessment.
2. Every 4 weeks until 28 weeks: Monitor weight, blood pressure, urine dipstick, and fetal heart tones.
3. Every 2 weeks from 28 to 36 weeks: Increase frequency for growth assessment, glucose screening, and Rhogam administration (if indicated).
4. Weekly from 36 weeks to delivery: Assess for labor signs, fetal presentation, and maternal complications such as preeclampsia.

Components of the Initial Prenatal Visit

• History: Obstetric, gynecologic, medical, surgical, family, genetic, psychosocial, and medication/allergy history.
• Physical Exam: Complete exam including pelvic assessment, clinical pelvimetry, and baseline vital signs.
• Laboratory Studies: CBC, blood type and Rh, antibody screen, rubella titer, syphilis screening, hepatitis B surface antigen, HIV test, urinalysis, and cervical cancer screening (if due). ^[5]
• Ultrasound: First-trimester dating ultrasound to confirm gestational age and viability.

Physiologic Adaptations of Pregnancy

Understanding these changes helps the FNP distinguish normal from pathologic findings:

• Cardiovascular: Increased blood volume (30–50%), increased cardiac output, decreased systemic vascular resistance, physiologic anemia of pregnancy.
• Respiratory: Increased minute ventilation, mild respiratory alkalosis, elevated diaphragm.
• Renal: Increased glomerular filtration rate (GFR), decreased serum creatinine and BUN, glycosuria (may be normal but must be distinguished from gestational diabetes).
• Gastrointestinal: Delayed gastric emptying, relaxation of lower esophageal sphincter (heartburn), nausea and vomiting (common in first trimester).
• Endocrine: Increased human chorionic gonadotropin (hCG), estrogen, progesterone, and human placental lactogen (hPL).

Recognizing Typical Pregnancy Complaints and Their Meaning

Common symptoms of pregnancy require appropriate counseling and management:

• Nausea and Vomiting: Affects up to 70% of pregnant women; usually resolves by 16 weeks. Severe cases may indicate hyperemesis gravidarum. ^[6]
• Fatigue: Common in first and third trimesters; often related to hormonal changes and sleep disruption.
• Urinary Frequency: Caused by increased renal output and later by fetal pressure on the bladder.
• Breast Changes: Tenderness, enlargement, and darkening of the areolae (due to estrogen and progesterone).
• Leukorrhea: Thin, white vaginal discharge; physiologic unless accompanied by itching, odor, or dysuria.
• Back Pain: Common due to lordosis and ligamentous relaxation; may require physical therapy and ergonomic support.
• Edema: Mild lower extremity edema is common; sudden or severe edema with hypertension raises concern for preeclampsia.

Gestational Dating, Screening Tests, and Diagnostic Criteria

Gestational Dating

Accurate dating is critical for all subsequent management decisions. ^[3]

• First trimester: Crown-rump length (CRL) by ultrasound is the most accurate method (±5–7 days).
• Second trimester: Biparietal diameter (BPD), femur length (FL), and head circumference (HC); accuracy ±7–14 days.
• Third trimester: Ultrasound dating is less reliable (error up to 3 weeks).

Key Screening Tests by Gestational Age

Diagnostic Criteria for Common Conditions

• Gestational Diabetes Mellitus (GDM): Carpenter-Coustan criteria — two or more abnormal values on 3-hour 100 g OGTT. ^[7]
• Preeclampsia: Blood pressure ≥140/90 mmHg on two occasions 4 hours apart after 20 weeks, with proteinuria (≥300 mg/24 hours) or end-organ dysfunction. ^[8]
• Anemia of Pregnancy: Hemoglobin <11 g/dL in first and third trimesters, <10.5 g/dL in second trimester. ^[5]

Nutritional Guidance, Immunizations, and Symptom Management

Nutrition and Supplementation

• Folic Acid: 400–800 mcg daily beginning at least 1 month before conception and throughout first trimester to prevent neural tube defects. ^[9]
• Iron: 27 mg/day is recommended; many prenatal vitamins contain this amount. Supplementation may be increased if anemia develops.
• Calcium: 1,000 mg/day (1,300 mg/day for adolescents). Adequate intake reduces the risk of hypertensive disorders. ^[10]
• Vitamin D: 600 IU/day (some guidelines suggest 1,000–2,000 IU/day for deficient populations).
• Weight Gain Recommendations (per IOM guidelines):
  • Underweight (BMI <18.5): 28–40 lbs
  • Normal weight (BMI 18.5–24.9): 25–35 lbs
  • Overweight (BMI 25–29.9): 15–25 lbs
  • Obese (BMI ≥30): 11–20 lbs

Immunizations in Pregnancy

• Influenza vaccine: Recommended during any trimester (inactivated form). ^[11]
• Tdap: Recommended at 27–36 weeks gestation (optimal window 27–30 weeks) to provide passive antibody transfer to the neonate. ^[12]
• COVID-19 vaccine: Recommended for pregnant individuals per CDC and ACOG guidelines. ^[13]
• Contraindicated: Live attenuated vaccines (MMR, varicella, LAIV) during pregnancy.

Common Discomforts and Conservative Management

• Nausea/Vomiting: Eat small, frequent meals; avoid triggers; consider vitamin B6 (10–25 mg TID) ± doxylamine (first-line pharmacotherapy). ^[6]
• Heartburn: Avoid lying down after meals; elevate head of bed; calcium-based antacids or H2-receptor antagonists (e.g., famotidine) are safe.
• Constipation: Increase fiber and water intake; stool softeners (e.g., docusate) if needed.
• Lower back pain: Pelvic tilt exercises, maternity support belts, acetaminophen (avoid NSAIDs after 20 weeks).

Emergency Red Flags and Medication Safety

Red Flags Requiring Immediate Attention

• Severe headache with visual changes — rule out preeclampsia.
• Vaginal bleeding — placenta previa, placental abruption, or threatened abortion.
• Rupture of membranes (fluid leakage) — confirm with speculum exam and AmniSure or pooling/ferning/test tape.
• Decreased fetal movement (<6 movements in 2 hours after 28 weeks) — initiate kick count monitoring.
• Signs of preterm labor (regular contractions before 37 weeks with cervical change).

Medication Safety in Pregnancy

• FDA Pregnancy Categories were phased out in 2015; now replaced by the Pregnancy and Lactation Labeling Rule (PLLR) with narrative risk summaries. ^[14]
• Avoid isotretinoin, statins, ACE inhibitors (especially in 2nd/3rd trimesters), warfarin, tetracyclines, and NSAIDs (after 20 weeks due to risk of oligohydramnios and premature ductus arteriosus closure). ^[15]
• Safe analgesics: Acetaminophen (preferred); use lowest effective dose.

Board-Relevant Pearls: Calculations, Red Flags, and Mnemonics

• Naegele's Rule: LMP + 7 days − 3 months = EDD. Example: LMP May 10 → EDD February 17. Memorize this for exam calculation questions.
• First-trimester bleeding: Common differentials include implantation bleeding, subchorionic hemorrhage, ectopic pregnancy, and spontaneous abortion. Quantitative β-hCG and ultrasound are critical for differentiation.
• Maternal serum alpha-fetoprotein (MSAFP): Elevated MSAFP → open neural tube defects (e.g., spina bifida). Low MSAFP → trisomy 21 (Down syndrome). ^[16]
• Doppler flow study: Useful for assessing umbilical artery resistance in cases of intrauterine growth restriction (IUGR).
• Biophysical Profile (BPP): Composite score (0–10 or 0–8) assessing fetal breathing, movement, tone, amniotic fluid volume, and (if included) non-stress test (NST). Score ≤6 indicates potential fetal compromise.
• Mnemonic for GBS risk factors: "PROM" — Preterm labor (<37 weeks), Rupture of membranes ≥18 hours, intrapartum Maternal fever (≥100.4°F).
• Rhogam indications: Administer at 28 weeks, within 72 hours of any bleeding or invasive procedure, and within 72 hours postpartum if the newborn is Rh-positive. ^[17]

References and Sources

1. American College of Obstetricians and Gynecologists (ACOG). Guidelines for Perinatal Care. 8th ed. ACOG; 2017. Guidelines for Perinatal Care
2. Lewis SL, Dirksen SR, Heitkemper MM, Bucher L, Camera IM. Medical-Surgical Nursing: Assessment and Management of Clinical Problems. 10th ed. Elsevier; 2016. https://shop.elsevier.com/books/medical-surgical-nursing/lewis/978-0-323-32852-4
3. Committee on Practice Bulletins—Obstetrics and the American Institute of Ultrasound in Medicine. Practice Bulletin No. 175: Ultrasound in Pregnancy. Obstet Gynecol. 2016;128(6):e241–e256. https://doi.org/10.1097/AOG.0000000000001815
4. Kilpatrick SJ, Papile LA, Macones GA, eds. Guidelines for Perinatal Care. 8th ed. American Academy of Pediatrics and American College of Obstetricians and Gynecologists; 2017. https://www.aap.org/Guidelines-for-Perinatal-Care-8th-edition-Paperback?srsltid=AfmBOor9Db_pwVuGN4OZ4iXc6ZWneEmmW2v7jeV0oP-Q9AMPlVkf21fT
5. American Academy of Family Physicians (AAFP). Recommended Clinical Preventive Services for Women. AAFP; 2021. https://www.aafp.org/afp/2021/0215/p209
6. Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 189: Nausea and Vomiting of Pregnancy. Obstet Gynecol. 2018;131(1):e15–e30. https://doi.org/10.1097/AOG.0000000000002456
7. American Diabetes Association (ADA). 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2021. Diabetes Care. 2021;44(Suppl 1):S15–S33. https://doi.org/10.2337/dc21-S002
8. ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstet Gynecol. 2019;133(1):e1–e25. https://doi.org/10.1097/AOG.0000000000003018
9. Centers for Disease Control and Prevention (CDC). Folic Acid: Recommendations for Women. 2023. https://www.cdc.gov/folic-acid/about/intake-and-sources.html
10. Institute of Medicine (IOM). Dietary Reference Intakes for Calcium and Vitamin D. National Academies Press; 2011. https://doi.org/10.17226/13050
11. Centers for Disease Control and Prevention (CDC). Influenza Vaccination During Pregnancy. 2023. https://www.cdc.gov/flu/vaccine-safety/vaccine-pregnant.html
12. ACOG Committee Opinion No. 718: Update on Immunization and Pregnancy. Obstet Gynecol. 2017;130(3):e172–e179. https://doi.org/10.1097/AOG.0000000000002191
13. Centers for Disease Control and Prevention (CDC). COVID-19 Vaccination for People Who Are Pregnant or Breastfeeding. 2023. https://www.cdc.gov/covid/vaccines/pregnant-or-breastfeeding.html
14. U.S. Food and Drug Administration (FDA). Pregnancy and Lactation Labeling (Drugs) Final Rule. 2014. https://www.fda.gov/drugs/labeling-information-drug-products/pregnancy-and-lactation-labeling-drugs-final-rule
15. Briggs GG, Freeman RK, Towers CV, Forinash AB. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 11th ed. Wolters Kluwer; 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC4989726/
16. ACOG Practice Bulletin No. 162: Prenatal Diagnostic Testing for Genetic Disorders. Obstet Gynecol. 2016;127(5):e108–e122. https://doi.org/10.1097/AOG.0000000000001405
17. ACOG Practice Bulletin No. 181: Prevention of Rh D Alloimmunization. Obstet Gynecol. 2017;130(2):e57–e68. https://doi.org/10.1097/AOG.0000000000002235